Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

A novel six-CpGs signature predicts clinical outcome in glioblastomas


ABSTRACT: We aimed to identify a clinically useful biomarker using DNA methylation-based information to optimize the management of glioblastoma (GBM) patients. We identified a novel six-CpGs signature that predicts the clinical outcome in GBM. The methylation profiling of 79 GBM patients has been used as a validation cohort to demonstrate the performance and the robustness of the identified six-CpGs signature. The status of the “MGMT” biomarker, traditionally used by clinicians to predict survival in GBM, is also indicated per sample.

ORGANISM(S): Homo sapiens

SUBMITTER: Amandine Etcheverry 

PROVIDER: E-MTAB-4969 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2013-05-13 | E-GEOD-39560 | biostudies-arrayexpress
2014-11-25 | E-GEOD-52793 | biostudies-arrayexpress
2015-03-27 | E-GEOD-67331 | biostudies-arrayexpress
2015-12-08 | E-GEOD-65638 | biostudies-arrayexpress
2013-06-01 | E-GEOD-32146 | biostudies-arrayexpress
2015-03-31 | E-GEOD-66210 | biostudies-arrayexpress
2016-02-01 | E-GEOD-72364 | biostudies-arrayexpress
2015-11-03 | E-GEOD-74414 | biostudies-arrayexpress
2014-12-25 | E-MTAB-3184 | biostudies-arrayexpress
2016-07-25 | E-GEOD-49504 | biostudies-arrayexpress